DKK4 and cancer: These results suggest that the transformation of fibroblasts by the reduced activity of β-catenin by an inhibitor in whole animal bodies can restrict the expansion of CRC tumours in mice and that the DKK4 change in cancer cells is able to alter the metastatic progression of CRC xenografts in mice.